ANO1 and neoplasm: Therefore, ANO1 holds dual value as both a therapeutic target and a biomarker in neoplastic diseases, facilitating patient prognosis assessment, risk stratification, and clinical decision-making, thereby advancing precision medicine and personalized treatment strategies.